Authors
Loading...
Hyporeactivity to repeated dsRNA may limit dosing regimens; leaves open human translation and therapeutic relevance.
Key points are not available for this paper at this time.
Erik De Clercq (1972) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: